{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T22:22:50Z","timestamp":1790374970906,"version":"4.1.0"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s00210-026-05279-9","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T04:14:18Z","timestamp":1776226458000},"page":"14439-14454","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Development, characterization, and evaluation of the therapeutic efficacy of PEGylated-nanoliposomal artesunate in mice bearing non-small cell lung carcinoma"],"prefix":"10.1007","volume":"399","author":[{"given":"Zemin","family":"Qin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianli","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranxin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5765-5934","authenticated-orcid":false,"given":"Junyan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,15]]},"reference":[{"key":"5279_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev-bioeng-071811-150124","volume":"14","author":"A Albanese","year":"2012","unstructured":"Albanese A, Tang PS, Chan WC (2012) The effect of nanoparticle size, shape, and surface chemistry on biological systems. Annu Rev Biomed Eng 14:1\u201316","journal-title":"Annu Rev Biomed Eng"},{"key":"5279_CR2","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/0169-409X(95)00029-7","volume":"16","author":"TM Allen","year":"1995","unstructured":"Allen TM, Hansen CB, de Menezes DEL (1995) Pharmacokinetics of long-circulating liposomes. Adv Drug Deliv Rev 16:267\u2013284","journal-title":"Adv Drug Deliv Rev"},{"key":"5279_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-025-02338-2","volume":"24","author":"H Allgayer","year":"2025","unstructured":"Allgayer H, Mahapatra S, Mishra B, Swain B, Saha S, Khanra S, Kumari K, Panda VK, Malhotra D, Patil NS (2025) Epithelial-to-mesenchymal transition (EMT) and cancer metastasis: the status quo of methods and experimental models 2025. Mol Cancer 24:167","journal-title":"Mol Cancer"},{"key":"5279_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2025.102500","volume":"35","author":"QK Anjani","year":"2025","unstructured":"Anjani QK, Volpe-Zanuto F, Miatmoko A, Moreno-Castellanos N, Novais JT, Gait\u00e1n XA, Hariawan BS, Cahyani DM, Octavia RT, Mubarok AS, Wahyu Setyaningsih WA, Johnston C, Bargieri DY, Donnelly RF (2025) Polymeric microarray patches for transdermal delivery of amodiaquine and artesunate: a novel strategy against Plasmodium falciparum. Materials Today Bio 35:102500","journal-title":"Materials Today Bio"},{"key":"5279_CR5","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1039\/D4PM00201F","volume":"1","author":"P Atre","year":"2024","unstructured":"Atre P, Rizvi SAA (2024) A brief overview of quality by design approach for developing pharmaceutical liposomes as nano-sized parenteral drug delivery systems. RSC Pharmaceutics 1:675\u2013688","journal-title":"RSC Pharmaceutics"},{"key":"5279_CR6","doi-asserted-by":"crossref","unstructured":"Bakrey H, Kaur P, Sharma A, Partap N, Shivgotra R, Soni B, Jain SK (2026) Functionalized liposomes in drug delivery. Functionalized Drug Delivery Systems. Elsevier, pp. 87\u2013114","DOI":"10.1016\/B978-0-443-33304-0.00050-2"},{"key":"5279_CR7","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/S0022-2836(65)80093-6","volume":"13","author":"AD Bangham","year":"1965","unstructured":"Bangham AD, Standish MM, Watkins JC (1965) Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol 13:238\u2013252","journal-title":"J Mol Biol"},{"key":"5279_CR8","first-page":"1599","volume":"14","author":"TG Berger","year":"2005","unstructured":"Berger TG, Dieckmann D, Efferth T, Schultz ES, Funk J-O, Baur A, Schuler G (2005a) Artesunate in the treatment of metastatic uveal melanoma-first experiences. Oncol Rep 14:1599\u20131603","journal-title":"Oncol Rep"},{"key":"5279_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics9020012","volume":"9","author":"U Bulbake","year":"2017","unstructured":"Bulbake U, Doppalapudi S, Kommineni N, Khan W (2017) Liposomal formulations in clinical use: an updated review. Pharmaceutics 9:12","journal-title":"Pharmaceutics"},{"key":"5279_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113705","volume":"155","author":"D Cao","year":"2022","unstructured":"Cao D, Chen D, Xia J-N, Wang W-Y, Zhu G-Y, Chen L-W, Zhang C, Tan B, Li H, Li Y-W (2022) Artesunate promoted anti-tumor immunity and overcame EGFR-TKI resistance in non-small-cell lung cancer by enhancing oncogenic TAZ degradation. Biomed Pharmacother 155:113705","journal-title":"Biomed Pharmacother"},{"key":"5279_CR11","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s11427-015-4988-z","volume":"59","author":"Z Chang","year":"2016","unstructured":"Chang Z (2016) The discovery of Qinghaosu (artemisinin) as an effective anti-malaria drug: a unique China story. Sci China Life Sci 59:81","journal-title":"Sci China Life Sci"},{"key":"5279_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.nxnano.2025.100209","volume":"8","author":"R Chelliah","year":"2025","unstructured":"Chelliah R, Rubab M, Vijayalakshmi S, Karuvelan M, Barathikannan K, Oh D-H (2025) Liposomes for drug delivery: classification, therapeutic applications, and limitations.\u00a0Next Nanotechnol\u00a08:100209","journal-title":"Next Nanotechnology"},{"key":"5279_CR13","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1128\/AAC.45.1.181-186.2001","volume":"45","author":"TME Davis","year":"2001","unstructured":"Davis TME, Phuong HL, Ilett KF, Hung NC, Batty KT, Phuong VDB, Powell SM, Thien HV, Binh TQ (2001) Pharmacokinetics and pharmacodynamics of intravenous artesunate in severe falciparum malaria. Antimicrob Agents Chemother 45:181\u2013186","journal-title":"Antimicrob Agents Chemother"},{"key":"5279_CR14","unstructured":"Dolan J (2009) Calibration curves, part II: what are the limits?"},{"key":"5279_CR15","first-page":"767","volume":"18","author":"T Efferth","year":"2001","unstructured":"Efferth T, Dunstan H, Sauerbrey A, Miyachi H, Chitambar CR (2001) The anti-malarial artesunate is also active against cancer. Int J Oncol 18:767\u2013773","journal-title":"Int J Oncol"},{"key":"5279_CR16","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1007\/s00228-014-1754-2","volume":"70","author":"T Ericsson","year":"2014","unstructured":"Ericsson T, Blank A, Von Hagens C, Ashton M, \u00c4bel\u00f6 A (2014) Population pharmacokinetics of artesunate and dihydroartemisinin during long-term oral administration of artesunate to patients with metastatic breast cancer. Eur J Clin Pharmacol 70:1453\u20131463","journal-title":"Eur J Clin Pharmacol"},{"key":"5279_CR17","doi-asserted-by":"crossref","unstructured":"Fanello C, Hoglund RM, Lee SJ, Kayembe D, Ndjowo P, Kabedi C, Badjanga BB, Niamyim P, Tarning J, Woodrow C, Gomes M, Day NP, White NJ, Onyamboko MA (2021) Pharmacokinetic study of rectal artesunate in children with severe malaria in Africa. Antimicrob Agents Chemother 65","DOI":"10.1128\/AAC.02223-20"},{"key":"5279_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24076615","author":"MD Fulton","year":"2023","unstructured":"Fulton MD, Najahi-Missaoui W (2023) Liposomes in cancer therapy: how did we start and where are we now. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms24076615","journal-title":"Int J Mol Sci"},{"key":"5279_CR19","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/S0731-7085(02)00678-7","volume":"31","author":"M Gabri\u00ebls","year":"2003","unstructured":"Gabri\u00ebls M, Plaizier-Vercammen J (2003) Physical and chemical evaluation of liposomes, containing artesunate. J Pharm Biomed Anal 31:655\u2013667","journal-title":"J Pharm Biomed Anal"},{"key":"5279_CR20","doi-asserted-by":"publisher","first-page":"4299","DOI":"10.1007\/s00216-014-7820-x","volume":"406","author":"MCK Geditz","year":"2014","unstructured":"Geditz MCK, Heinkele G, Ahmed A, Kremsner PG, Kerb R, Schwab M, Hofmann U (2014) LC-MS\/MS method for the simultaneous quantification of artesunate and its metabolites dihydroartemisinin and dihydroartemisinin glucuronide in human plasma. Anal Bioanal Chem 406:4299\u20134308","journal-title":"Anal Bioanal Chem"},{"key":"5279_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-022-01569-5","volume":"20","author":"L Gu","year":"2022","unstructured":"Gu L, Zhang J, Liu D, Chen J, Liu S, Peng Q, Tian Y, Du M, Zhang J, Xiao W (2022) Development of artesunate intelligent prodrug liposomes based on mitochondrial targeting strategy. J Nanobiotechnology 20:376","journal-title":"J Nanobiotechnology"},{"key":"5279_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13081885","volume":"13","author":"KS Hill","year":"2021","unstructured":"Hill KS, McDowell A, McCorkle JR, Schuler E, Ellingson SR, Plattner R, Kolesar JM (2021) KEAP1 is required for artesunate anticancer activity in non-small-cell lung cancer. Cancers 13:1885","journal-title":"Cancers"},{"key":"5279_CR23","doi-asserted-by":"publisher","first-page":"5519","DOI":"10.1158\/1078-0432.CCR-08-0197","volume":"14","author":"J Hou","year":"2008","unstructured":"Hou J, Wang D, Zhang R, Wang H (2008) Experimental therapy of hepatoma with artemisinin and its derivatives: in vitro and in vivo activity, chemosensitization, and mechanisms of action. Clin Cancer Res 14:5519\u20135530","journal-title":"Clin Cancer Res"},{"key":"5279_CR24","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1080\/03639045.2018.1483383","volume":"44","author":"C Hu","year":"2018","unstructured":"Hu C, Liang K, An R, Wang X, You L (2018) The characterization, pharmacokinetic, and tissue distribution studies of TPGS-modified artesunate liposome in rats. Drug Dev Ind Pharm 44:1528\u20131535","journal-title":"Drug Dev Ind Pharm"},{"key":"5279_CR25","doi-asserted-by":"publisher","first-page":"6590","DOI":"10.1080\/21655979.2022.2042141","volume":"13","author":"P Hu","year":"2022","unstructured":"Hu P, Ni C, Teng P (2022) Effects of artesunate on the malignant biological behaviors of non-small cell lung cancer in human and its mechanism. Bioengineered 13:6590\u20136599","journal-title":"Bioengineered"},{"key":"5279_CR26","doi-asserted-by":"publisher","first-page":"15702","DOI":"10.1021\/ja8065557","volume":"130","author":"Z Huang","year":"2008","unstructured":"Huang Z, Szoka JFC (2008) Sterol-modified phospholipids: cholesterol and phospholipid chimeras with improved biomembrane properties. J Am Chem Soc 130:15702\u201315712","journal-title":"J Am Chem Soc"},{"key":"5279_CR27","first-page":"6774","volume":"52","author":"SK Huang","year":"1992","unstructured":"Huang SK, Mayhew E, Gilani S, Lasic DD, Martin FJ, Papahadjopoulos D (1992) Pharmacokinetics and therapeutics of sterically stabilized liposomes in mice bearing C-26 colon carcinoma. Cancer Res 52:6774\u20136781","journal-title":"Cancer Res"},{"key":"5279_CR28","doi-asserted-by":"publisher","first-page":"4210","DOI":"10.1002\/ange.200900111","volume":"121","author":"Z Huang","year":"2009","unstructured":"Huang Z, Jaafari MR, Szoka JFC (2009) Disterolphospholipids: nonexchangeable lipids and their application to liposomal drug delivery. Angew Chem 121:4210\u20134213","journal-title":"Angew Chem"},{"key":"5279_CR29","doi-asserted-by":"publisher","first-page":"237","DOI":"10.3109\/08982104.2010.539185","volume":"21","author":"B Isacchi","year":"2011","unstructured":"Isacchi B, Arrigucci S, Gl M, Bergonzi MC, Vannucchi MG, Novelli A, Bilia AR (2011) Conventional and long-circulating liposomes of artemisinin: preparation, characterization, and pharmacokinetic profile in mice. J Liposome Res 21:237\u2013244","journal-title":"J Liposome Res"},{"key":"5279_CR30","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.ejpb.2011.11.015","volume":"80","author":"B Isacchi","year":"2012","unstructured":"Isacchi B, Bergonzi MC, Grazioso M, Righeschi C, Pietretti A, Severini C, Bilia AR (2012) Artemisinin and artemisinin plus curcumin liposomal formulations: enhanced antimalarial efficacy against Plasmodium berghei-infected mice. Eur J Pharm Biopharm 80:528\u2013534","journal-title":"Eur J Pharm Biopharm"},{"key":"5279_CR31","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.apsb.2015.07.003","volume":"5","author":"S Kalepu","year":"2015","unstructured":"Kalepu S, Nekkanti V (2015) Insoluble drug delivery strategies: review of recent advances and business prospects. Acta Pharm Sin B 5:442\u2013453","journal-title":"Acta Pharm Sin B"},{"key":"5279_CR32","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2165\/00044011-199815010-00005","volume":"15","author":"J Karbwang","year":"1998","unstructured":"Karbwang J, Na-Bangchang K, Congpoung K, Thanavibul A, Harinasuta T (1998a) Pharmacokinetics of oral artesunate in thai patients with uncomplicated falciparum malaria. Clin Drug Investig 15:37\u201343","journal-title":"Clin Drug Investig"},{"key":"5279_CR33","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.actbio.2025.02.035","volume":"195","author":"M Karimi","year":"2025","unstructured":"Karimi M, Aslanabadi A, Atkinson B, Hojabri M, Munawwar A, Zareidoodeji R, Ray K, Habibzadeh P, Parlayan HNK, DeVico A (2025) Subcutaneous liposomal delivery improves monoclonal antibody pharmacokinetics in vivo. Acta Biomater 195:522\u2013535","journal-title":"Acta Biomater"},{"key":"5279_CR34","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.colsurfb.2012.06.024","volume":"101","author":"NM Khalil","year":"2013","unstructured":"Khalil NM, do Nascimento TCF, Casa DM, Dalmolin LF, de Mattos AC, Hoss I, Romano MA, Mainardes RM (2013) Pharmacokinetics of curcumin-loaded PLGA and PLGA\u2013PEG blend nanoparticles after oral administration in rats. Colloids Surf B Biointerfaces 101:353\u2013360","journal-title":"Colloids Surf B Biointerfaces"},{"key":"5279_CR35","unstructured":"Kim S-H, Kim JM, Shin M-h, Kim CW, Huang S-M, Kang DW, Suh KS, Yi ES, Kim KH (2012) Correlation of epithelial-mesenchymal transition markers with clinicopathologic parameters in adenocarcinomas and squamous cell carcinoma of the lung."},{"key":"5279_CR36","doi-asserted-by":"publisher","first-page":"276","DOI":"10.3390\/pharmaceutics17020276","volume":"17","author":"A Kozak","year":"2025","unstructured":"Kozak A, Lavrih E, Mikhaylov G, Turk B, Vasiljeva O (2025) Navigating the clinical landscape of liposomal therapeutics in cancer treatment. Pharmaceutics 17:276","journal-title":"Pharmaceutics"},{"key":"5279_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12105-025-01863-2","volume":"19","author":"D Kumar","year":"2025","unstructured":"Kumar D, Gupta A, Agrahari S, Singh S, Gupta S, Kumar V, Singh SK (2025) Association of epithelial to mesenchymal transition markers on prognosis and clinicopathological characteristics in oral squamous cell carcinoma: a systematic review and meta-analysis. Head Neck Pathol 19:1\u201317","journal-title":"Head Neck Pathol"},{"key":"5279_CR38","doi-asserted-by":"publisher","DOI":"10.1142\/s0192415x25500922","author":"J Li","year":"2025","unstructured":"Li J, Zheng J, Cui Y, Liu Y, Fan H, Wang X, Liu H, Li X, Yu G, Luo Z (2025) The role of artesunate in cancer management: mechanisms of biomedical effects and toxicology. Am J Chin Med. https:\/\/doi.org\/10.1142\/s0192415x25500922","journal-title":"Am J Chin Med"},{"key":"5279_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2020.145134","volume":"766","author":"W Li","year":"2021","unstructured":"Li W, Ma G, Deng Y, Wu Q, Wang Z, Zhou Q (2021) Artesunate exhibits synergistic anti-cancer effects with cisplatin on lung cancer A549 cells by inhibiting MAPK pathway. Gene 766:145134","journal-title":"Gene"},{"key":"5279_CR40","doi-asserted-by":"publisher","first-page":"3523","DOI":"10.1111\/ijfs.17110","volume":"59","author":"B Liu","year":"2024","unstructured":"Liu B, Zan L, Li X, Cai Y, Hao G (2024) Modification of liposomes: preparation, purpose, methods and the application in food. Int J Food Sci Technol 59:3523\u20133536","journal-title":"Int J Food Sci Technol"},{"key":"5279_CR41","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3109\/08982109209039901","volume":"2","author":"D Liu","year":"1992","unstructured":"Liu D, Huang L (1992) Size homogeneity of a liposome preparation is crucial for liposome biodistribution in vivo. J Liposome Res 2:57\u201366","journal-title":"J Liposome Res"},{"key":"5279_CR42","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1080\/08982104.2025.2561825","volume":"35","author":"XS Lu","year":"2025","unstructured":"Lu XS, Yang LQ, Ma L, Wu JF, Zhang HB, Wang Y (2025) Liposome stability: multifactorial regulation and optimization strategies in in vivo delivery. J Liposome Res 35:607\u2013618","journal-title":"J Liposome Res"},{"key":"5279_CR43","doi-asserted-by":"publisher","first-page":"4417","DOI":"10.1021\/jf500698k","volume":"62","author":"Y Luo","year":"2014","unstructured":"Luo Y, Zhang Y, Pan K, Critzer F, Davidson PM, Zhong Q (2014) Self-emulsification of alkaline-dissolved clove bud oil by whey protein, gum arabic, lecithin, and their combinations. J Agric Food Chem 62:4417\u20134424","journal-title":"J Agric Food Chem"},{"key":"5279_CR44","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/S0378-4347(97)00667-1","volume":"708","author":"K Na-Bangchang","year":"1998","unstructured":"Na-Bangchang K, Congpuong K, Hung LN, Molunto P, Karbwang J (1998) Simple high-performance liquid chromatographic method with electrochemical detection for the simultaneous determination of artesunate and dihydroartemisinin in biological fluids. J Chromatogr B Biomed Sci Appl 708:201\u2013207","journal-title":"J Chromatogr B Biomed Sci Appl"},{"key":"5279_CR45","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1002\/hed.20524","volume":"29","author":"W Nam","year":"2007","unstructured":"Nam W, Tak J, Ryu JK, Jung M, Yook JI, Kim HJ, Cha IH (2007) Effects of artemisinin and its derivatives on growth inhibition and apoptosis of oral cancer cells. Head Neck 29:335\u2013340","journal-title":"Head Neck"},{"key":"5279_CR46","doi-asserted-by":"publisher","first-page":"190","DOI":"10.3390\/pharmaceutics17020190","volume":"17","author":"S Peter","year":"2025","unstructured":"Peter S, Khwaza V, Alven S, Naki T, Aderibigbe BA (2025a) Pegylated nanoliposomes encapsulated with anticancer drugs for breast and prostate cancer therapy: an update. Pharmaceutics 17:190","journal-title":"Pharmaceutics"},{"key":"5279_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics17020190","author":"S Peter","year":"2025","unstructured":"Peter S, Khwaza V, Alven S, Naki T, Aderibigbe BA (2025b) PEGylated nanoliposomes encapsulated with anticancer drugs for breast and prostate cancer therapy: an update. Pharmaceutics. https:\/\/doi.org\/10.3390\/pharmaceutics17020190","journal-title":"Pharmaceutics"},{"key":"5279_CR48","doi-asserted-by":"publisher","first-page":"41794","DOI":"10.1039\/C9RA07707C","volume":"9","author":"N Puttappa","year":"2019","unstructured":"Puttappa N, Yamjala K, Raman SK, Kuppusamy G, Babu B, Kumar PR (2019) A simple sensitive UFLC-MS\/MS method for the simultaneous quantification of artesunate, dihydroartemisinin and quercetin in rat plasma and its application to pharmacokinetic studies. RSC Adv 9:41794\u201341802","journal-title":"RSC Adv"},{"key":"5279_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14050989","author":"GS Ramos","year":"2022","unstructured":"Ramos GS, Vallejos VMR, Borges GSM, Almeida RM, Alves IM, Aguiar MMG, Fernandes C, Guimar\u00e3es PPG, Fujiwara RT, Loiseau PM, Ferreira LAM, Fr\u00e9zard F (2022) Formulation of amphotericin B in PEGylated liposomes for improved treatment of cutaneous leishmaniasis by parenteral and oral routes. Pharmaceutics. https:\/\/doi.org\/10.3390\/pharmaceutics14050989","journal-title":"Pharmaceutics"},{"key":"5279_CR50","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26083617","volume":"26","author":"MC Rapanotti","year":"2025","unstructured":"Rapanotti MC, Cugini E, Scioli MG, Cenci T, Anzillotti S, Puzzuoli M, Terrinoni A, Ferlosio A, De Luca A, Orlandi A (2025) The clinical relevance of epithelial-to-mesenchymal transition hallmarks: a cut-off-based approach in healthy and cancerous cell lines. Int J Mol Sci 26:3617","journal-title":"Int J Mol Sci"},{"key":"5279_CR51","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1002\/ijc.25315","volume":"127","author":"SA Rasheed","year":"2010","unstructured":"Rasheed SA, Efferth T, Asangani IA, Allgayer H (2010a) First evidence that the antimalarial drug artesunate inhibits invasion and in vivo metastasis in lung cancer by targeting essential extracellular proteases. Int J Cancer 127:1475\u20131485","journal-title":"Int J Cancer"},{"key":"5279_CR52","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ijpharm.2018.01.039","volume":"540","author":"MM Riahi","year":"2018","unstructured":"Riahi MM, Sahebkar A, Sadri K, Nikoofal-Sahlabadi S, Jaafari M (2018) Stable and sustained release liposomal formulations of celecoxib: in vitro and in vivo anti-tumor evaluation. Int J Pharm 540:89\u201397","journal-title":"Int J Pharm"},{"key":"5279_CR53","doi-asserted-by":"publisher","DOI":"10.3390\/molecules30224408","volume":"30","author":"F Ruggieri","year":"2025","unstructured":"Ruggieri F, Maggi MA, Commito F, Badia F, Giansanti L (2025) Fractionation of saffron (Crocus sativus L.) extract by solid-phase extraction and subsequent encapsulation in liposomes prepared by reverse-phase evaporation. Molecules 30:4408","journal-title":"Molecules"},{"key":"5279_CR54","doi-asserted-by":"publisher","DOI":"10.3390\/nano7020037","author":"M Sangr\u00e0","year":"2017","unstructured":"Sangr\u00e0 M, Estelrich J, Sabat\u00e9 R, Espargar\u00f3 A, Busquets MA (2017) Evidence of protein adsorption in pegylated liposomes: influence of liposomal decoration. Nanomaterials. https:\/\/doi.org\/10.3390\/nano7020037","journal-title":"Nanomaterials"},{"key":"5279_CR55","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1158\/1078-0432.CCR-05-1566","volume":"12","author":"T Schluep","year":"2006","unstructured":"Schluep T, Hwang J, Cheng J, Heidel JD, Bartlett DW, Hollister B, Davis ME (2006) Preclinical efficacy of the camptothecin-polymer conjugate IT-101 in multiple cancer models. Clin Cancer Res 12:1606\u20131614","journal-title":"Clin Cancer Res"},{"key":"5279_CR56","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1039\/D4PM00176A","volume":"1","author":"RM Senjab","year":"2024","unstructured":"Senjab RM, AlSawaftah N, Abuwatfa WH, Husseini GA (2024) Advances in liposomal nanotechnology: from concept to clinics. RSC Pharmaceutics 1:928\u2013948","journal-title":"RSC Pharmaceutics"},{"key":"5279_CR57","first-page":"9","volume":"19","author":"S Shen","year":"2013","unstructured":"Shen S, Liu SZ, Du MB, Ge KY, Song LH, Ye ZG (2013) Determination of equilibrium solubility and apparent oil\/water partition coefficient of artesunate. Chin J Exp Tradit Med Formulae 19:9\u201312","journal-title":"Chin J Exp Tradit Med Formulae"},{"key":"5279_CR58","doi-asserted-by":"crossref","unstructured":"Siegel RL, Giaquinto AN, Jemal A (2024) Cancer statistics, 2024. CA: a cancer journal for clinicians 74","DOI":"10.3322\/caac.21820"},{"key":"5279_CR59","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics17070885","author":"\u017b Sobol","year":"2025","unstructured":"Sobol \u017b, Chiczewski R, W\u0105tr\u00f3bska-\u015awietlikowska D (2025) Advances in liposomal drug delivery: multidirectional perspectives on overcoming biological barriers. Pharmaceutics. https:\/\/doi.org\/10.3390\/pharmaceutics17070885","journal-title":"Pharmaceutics"},{"key":"5279_CR60","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-025-01679-1","volume":"18","author":"P-L Su","year":"2025","unstructured":"Su P-L, Furuya N, Asrar A, Rolfo C, Li Z, Carbone DP, He K (2025) Recent advances in therapeutic strategies for non-small cell lung cancer. J Hematol Oncol 18:35","journal-title":"J Hematol Oncol"},{"key":"5279_CR61","doi-asserted-by":"publisher","DOI":"10.1007\/s11427-015-4948-7","volume-title":"The discovery of artemisinin and the Nobel Prize in physiology or medicine","author":"X-Z Su","year":"2015","unstructured":"Su X-Z, Miller LH (2015) The discovery of artemisinin and the Nobel Prize in physiology or medicine. Springer"},{"key":"5279_CR62","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1097\/00000542-200409000-00015","volume":"101","author":"CH Svens\u00e9n","year":"2004","unstructured":"Svens\u00e9n CH, Brauer KP, Hahn RG, Uchida T, Traber LD, Traber DL, Prough DS (2004) Elimination rate constant describing clearance of infused fluid from plasma is independent of large infusion volumes of 0.9% saline in sheep. Anesthesiology 101:666\u2013674","journal-title":"Anesthesiology"},{"key":"5279_CR63","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s44301-025-00014-4","volume":"1","author":"F Taghavimandi","year":"2025","unstructured":"Taghavimandi F, Kim MG, Lee M, Shin K (2025) Beyond PEGylation: nanoparticle surface modulation for enhanced cancer therapy. Health Nanotechnol 1:13","journal-title":"Health Nanotechnol"},{"key":"5279_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e13823","volume":"9","author":"M Taher","year":"2023","unstructured":"Taher M, Susanti D, Haris MS, Rushdan AA, Widodo RT, Syukri Y, Khotib J (2023) PEGylated liposomes enhance the effect of cytotoxic drug: a review. Heliyon 9:e13823","journal-title":"Heliyon"},{"key":"5279_CR65","doi-asserted-by":"publisher","first-page":"e864","DOI":"10.1093\/cid\/ciac728","volume":"76","author":"CM Thomas","year":"2023","unstructured":"Thomas CM, Stauffer WM, Alpern JD (2023) Food and drug administration approval of artesunate for severe malaria: enough to achieve best practice? Clin Infect Dis 76:e864\u2013e866","journal-title":"Clin Infect Dis"},{"key":"5279_CR66","first-page":"22045","volume":"8","author":"H Tong","year":"2015","unstructured":"Tong H, Wang Y, Lu X, Wang P, Zhao S, Chang H, Yu X (2015) On the preparation of transferrin modified artesunate nanoliposomes and their glioma-targeting treatment in-vitro and in-vivo. Int J Clin Exp Med 8:22045","journal-title":"Int J Clin Exp Med"},{"key":"5279_CR67","doi-asserted-by":"publisher","first-page":"31413","DOI":"10.18632\/oncotarget.8920","volume":"7","author":"Y Tong","year":"2016","unstructured":"Tong Y, Liu Y, Zheng H, Zheng L, Liu W, Wu J, Ou R, Zhang G, Li F, Hu M (2016) Artemisinin and its derivatives can significantly inhibit lung tumorigenesis and tumor metastasis through Wnt\/\u03b2-catenin signaling. Oncotarget 7:31413","journal-title":"Oncotarget"},{"key":"5279_CR68","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/nrd1632","volume":"4","author":"VP Torchilin","year":"2005","unstructured":"Torchilin VP (2005) Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov 4:145\u2013160","journal-title":"Nat Rev Drug Discov"},{"key":"5279_CR69","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.3109\/21691401.2015.1129616","volume":"44","author":"TH Tran","year":"2016","unstructured":"Tran TH, Nguyen AN, Kim JO, Yong CS, Nguyen CN (2016) Enhancing activity of artesunate against breast cancer cells via induced-apoptosis pathway by loading into lipid carriers. Artif Cells Nanomed Biotechnol 44:1979\u20131987","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"5279_CR70","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1208\/s12249-015-0311-3","volume":"16","author":"TH Tran","year":"2015","unstructured":"Tran TH, Nguyen TD, Poudel BK, Nguyen HT, Kim JO, Yong CS, Nguyen CN (2015) Development and evaluation of artesunate-loaded chitosan-coated lipid nanocapsule as a potential drug delivery system against breast cancer. AAPS PharmSciTech 16:1307\u20131316","journal-title":"AAPS PharmSciTech"},{"key":"5279_CR71","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.apjtb.2016.04.009","volume":"6","author":"M-Y Wang","year":"2016","unstructured":"Wang M-Y (2016) Publication process involving the discovery of artemisinin (qinghaosu) before 1985. Asian Pac J Trop Biomed 6:461\u2013467","journal-title":"Asian Pac J Trop Biomed"},{"key":"5279_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.113381","volume":"143","author":"Q Wang","year":"2024","unstructured":"Wang Q, Zhou J, Cheng A, Liu Y, Guo J, Li X, Chen M, Hu D, Wu J (2024) Artesunate-binding FABP5 promotes apoptosis in lung cancer cells via the PPAR\u03b3-SCD pathway. Int Immunopharmacol 143:113381","journal-title":"Int Immunopharmacol"},{"key":"5279_CR73","doi-asserted-by":"publisher","first-page":"603","DOI":"10.5732\/cjc.011.10226","volume":"30","author":"Y Wang","year":"2011","unstructured":"Wang Y, Zhou BP (2011) Epithelial-mesenchymal transition in breast cancer progression and metastasis. Chin J Cancer 30:603","journal-title":"Chin J Cancer"},{"key":"5279_CR74","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1111\/1440-1681.13287","volume":"47","author":"Z Wang","year":"2020","unstructured":"Wang Z, Wang Q, He T, Li W, Liu Y, Fan Y, Wang Y, Wang Q, Chen J (2020) The combination of artesunate and carboplatin exerts a synergistic anti-tumour effect on non-small cell lung cancer. Clin Exp Pharmacol Physiol 47:1083\u20131091","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"5279_CR75","volume-title":"Guidelines for the treatment of malaria","author":"World Health O","year":"2015","unstructured":"World Health O (2015) Guidelines for the treatment of malaria. World Health Organization"},{"key":"5279_CR76","doi-asserted-by":"publisher","first-page":"391","DOI":"10.2174\/2211738508666200813141454","volume":"8","author":"P Xiao","year":"2020","unstructured":"Xiao P, Zhao J, Huang Y, Jin R, Tang Z, Wang P, Song X, Zhu H, Yang Z, Yu N (2020) A novel long-circulating DOX liposome: formulation and pharmacokinetics studies. Pharm Nanotechnol 8:391\u2013398","journal-title":"Pharm Nanotechnol"},{"key":"5279_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2021.111937","volume":"206","author":"B Xiong","year":"2021","unstructured":"Xiong B, Chen Y, Liu Y, Hu X, Han H, Li Q (2021) Artesunate-loaded porous PLGA microsphere as a pulmonary delivery system for the treatment of non-small cell lung cancer. Colloids Surf B Biointerfaces 206:111937","journal-title":"Colloids Surf B Biointerfaces"},{"key":"5279_CR78","doi-asserted-by":"publisher","first-page":"5436","DOI":"10.1016\/j.cell.2025.08.033","volume":"188","author":"CX Zhang","year":"2025","unstructured":"Zhang CX, Huang RY-J, Sheng G, Thiery JP (2025) Epithelial-mesenchymal transition. Cell 188:5436\u20135486","journal-title":"Cell"},{"key":"5279_CR79","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S444076","author":"J Zhang","year":"2024","unstructured":"Zhang J, Gu L, Jiang Y, Ma Y, Zhang Z, Shen S, Shen S, Peng Q, Xiao W (2024) Artesunate-nanoliposome-TPP, a novel drug delivery system that targets the mitochondria, attenuates cisplatin-induced acute kidney injury by suppressing oxidative stress and inflammatory effects.\u00a0Int J Nanomed. https:\/\/doi.org\/10.2147\/IJN.S444076","journal-title":"International Journal of Nanomedicine"},{"key":"5279_CR80","first-page":"134","volume":"6","author":"Z-Y Zhang","year":"2008","unstructured":"Zhang Z-Y, Yu S-Q, Miao L-Y, Huang X-Y, Zhang X-P, Zhu Y-P, Xia X-H, Li D-Q (2008) Artesunate combined with vinorelbine plus cisplatin in treatment of advanced non-small cell lung cancer: a randomized controlled trial.\u00a0Zhong Xi Yi Jie He Xue Bao Chin J Integr Med\u00a06:134\u2013138","journal-title":"Zhong Xi Yi Jie He Xue Bao= Journal of Chinese Integrative Medicine"},{"key":"5279_CR81","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1016\/j.intimp.2011.08.017","volume":"11","author":"Y Zhao","year":"2011","unstructured":"Zhao Y, Jiang W, Li B, Yao Q, Dong J, Cen Y, Pan X, Li J, Zheng J, Pang X (2011) Artesunate enhances radiosensitivity of human non-small cell lung cancer A549 cells via increasing NO production to induce cell cycle arrest at G2\/M phase.\u00a0Int Immunopharmacol\u00a011: 2039-2046","journal-title":". International immunopharmacology"},{"key":"5279_CR82","first-page":"3017","volume":"22","author":"Y Zhao","year":"2020","unstructured":"Zhao Y, Liu J, Liu L (2020) Artesunate inhibits lung cancer cells via regulation of mitochondrial membrane potential and induction of apoptosis. Mol Med Rep 22: 3017-3022","journal-title":"Mol Med Rep"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05279-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05279-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05279-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T03:43:39Z","timestamp":1783914219000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-026-05279-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,15]]},"references-count":82,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["5279"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05279-9","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,15]]},"assertion":[{"value":"5 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study adheres to internationally accepted standards for animal research, following the 3Rs principle approved by the Institutional Ethical Committee and Research Advisory Committee of Heping Hospital Affiliated to Changzhi Medical College, Chazhi, China (HCMC15672025). The ARRIVE guidelines were employed for reporting experiments involving live animals, promoting ethical research practices.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}},{"value":"The authors declare that there are no conflicts of interest for the present study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}